MAP2K7 and gastric cancer: Mesenchymal stem cells (MSC) are known to be involved in chemotherapeutic drug resistance and MSC-exosomes have been implicated in promoting drug resistance in gastric cancer by activating the calcium/calmodulin-dependent protein kinase (CaM-Ks) and Raf/MEK/ERK kinase cascade [46].